Recent Articles
Can VEGFR Antibodies Become a Ne...
Th1/Th2 Subset Differentiation: ...
Paired Antibodies for Progestero...
Custom Antibody Development for Parkinson’s Disease: Precision Probes to Capt...
Parkinson’s disease research requires selective antibodies to track monomeric, oligomeric and fibrillar α-synuclein, phosphorylated variants and familial mutation isoforms. Standard commercial reagents lack conformation-specific binding capacity. ANT BIO offers end-to-end...
Custom Antibody Development for Parkinson’s Disease: Precision Probes to Capt...
Parkinson’s disease research requires selective antibodies to track monomeric, oligomeric and fibrillar α-synuclein, phosphorylated variants and familial mutation isoforms. Standard commercial reagents lack conformation-specific binding capacity. ANT BIO offers end-to-end...
Read More
Arginine Methylation Networks: Coordinated Modulation of Alternative Splicing...
PRMT enzymes are categorized into three subtypes that catalyze distinct arginine methylation modifications. PRMT4, PRMT5 and PRMT7 jointly modify splicing factors including hnRNPA1 to drive oncogenic alternative splicing in multiple...
Arginine Methylation Networks: Coordinated Modulation of Alternative Splicing...
PRMT enzymes are categorized into three subtypes that catalyze distinct arginine methylation modifications. PRMT4, PRMT5 and PRMT7 jointly modify splicing factors including hnRNPA1 to drive oncogenic alternative splicing in multiple...
Read More
Evolved Antibody-drug Conjugates Evaluation Assays
Overview of ADCs Antibody-Drug Conjugates (ADCs), known as "biological missiles", combine tumor-targeting specificity of monoclonal antibodies with potent cytotoxic payloads. ADC drug development encounters severe technical challenges across target identification,...
Evolved Antibody-drug Conjugates Evaluation Assays
Overview of ADCs Antibody-Drug Conjugates (ADCs), known as "biological missiles", combine tumor-targeting specificity of monoclonal antibodies with potent cytotoxic payloads. ADC drug development encounters severe technical challenges across target identification,...
Read More
Evolved Antibody-drug Conjugates Raw Materials
Overview of ADCs Antibody-Drug Conjugates (ADCs), known as "biological missiles", combine tumor-targeting specificity of monoclonal antibodies with potent cytotoxic payloads. ADC drug development encounters severe technical challenges across target identification,...
Evolved Antibody-drug Conjugates Raw Materials
Overview of ADCs Antibody-Drug Conjugates (ADCs), known as "biological missiles", combine tumor-targeting specificity of monoclonal antibodies with potent cytotoxic payloads. ADC drug development encounters severe technical challenges across target identification,...
Read More
Pan-Ubiquitin Antibody: Foundational PTM Reagent for Ubiquitin-Proteasome and...
Ubiquitination is a vital reversible post-translational modification controlling proteolysis, DNA repair and immune signaling, with distinct K48/K63 ubiquitin chains mediating divergent cellular functions. ANT BIO S0B0087 pan-ubiquitin recombinant rabbit mAb...
Pan-Ubiquitin Antibody: Foundational PTM Reagent for Ubiquitin-Proteasome and...
Ubiquitination is a vital reversible post-translational modification controlling proteolysis, DNA repair and immune signaling, with distinct K48/K63 ubiquitin chains mediating divergent cellular functions. ANT BIO S0B0087 pan-ubiquitin recombinant rabbit mAb...
Read More
CCL17 Chemokine Detection Tools: One-Step Human CCL17 ELISA Kit for Autoimmun...
CCL17 (TARC) is a critical CC chemokine recruiting CCR4+ Treg and Th2 cells, participating in autoimmune inflammation, tumor immune escape and tissue fibrosis. Conventional multi-step CCL17 ELISA suffers from lengthy...
CCL17 Chemokine Detection Tools: One-Step Human CCL17 ELISA Kit for Autoimmun...
CCL17 (TARC) is a critical CC chemokine recruiting CCR4+ Treg and Th2 cells, participating in autoimmune inflammation, tumor immune escape and tissue fibrosis. Conventional multi-step CCL17 ELISA suffers from lengthy...
Read More